-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CFdfXXlNQXLr0Cexqx3hnxsImrSDwRolj+MU256TcYNPrED4Cx1/zB464ZBjj0VQ jIgmin0KFxi7Utf18DonCQ== 0000943440-06-000061.txt : 20060210 0000943440-06-000061.hdr.sgml : 20060210 20060209173514 ACCESSION NUMBER: 0000943440-06-000061 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060210 DATE AS OF CHANGE: 20060209 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KRAVITZ PAUL CENTRAL INDEX KEY: 0001179206 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: BUSINESS PHONE: 5617501100 MAIL ADDRESS: STREET 1: 7284 W. PALMETTO PARK RD STREET 2: SUITE 106 CITY: BOCA RATON STATE: FL ZIP: 33433 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MED GEN INC CENTRAL INDEX KEY: 0001045707 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 650703559 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-78404 FILM NUMBER: 06594450 BUSINESS ADDRESS: STREET 1: 7284 W PALMETTO ROAD STREET 2: SUITE 106 CITY: BOCA RATON STATE: FL ZIP: 33433 BUSINESS PHONE: 5617501100 MAIL ADDRESS: STREET 1: 7284 W PALMETTO ROAD STREET 2: SUITE 106 CITY: BOCA RATON STATE: FL ZIP: 33433 SC 13D 1 kravitz-feb0613d.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Under the Securities Exchange Act of 1934 (Amendment No. ______) MED GEN, INC. - ----------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 Par Value Per Share - ------------------------------------------------------------------------ (Title of Class of Securities) 58401X-2-09 - ----------------------------------------------------------------------- (CUSIP Number) Paul Mitchell, President Med Gen, Inc. 7284 W. Palmetto Park Road, Suite 207 Boca Raton, Florida 33433 (561) 750-1100 - ----------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) February 8th, 2006 - ----------------------------------------------------------------------- Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this Schedule because of Rule 13d-1(b)(3) or (4), check the following box: [ ]. Note. Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. (Continued on following pages) (Page 1 of 5 Pages) 13D CUSIP NO.58401X-20-9 Page 2 of 5 Pages 1. Names of Reporting Persons. I.R.S. Identification Nos. of above Persons Paul Kravitz 2. Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3. SEC Use Only 4. Source of Funds SC 5. Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6. Citizenship or Place of Organization Paul Kravitz - United States Number of Shares Beneficially Owned by Each Reporting Person With: 7. Sole Voting Power 10,178,685 8. Shared Voting Power -0- 9. Sole Dispositive Power 10,178,685 10. Shared Dispositive Power -0- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 10,178,685 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares [ ] CUSIP NO. 58401X-20-9 Page 3 of 5 Pages 13. Percent of Class Represented by Amount of Row (11): 43.83% 14. Type of Reporting Person: IN ITEM 1. SECURITY AND ISSUER The class of equity securities to which this Schedule 13D relates is the common stock, $.001 par value, of Med Gen, Inc., a Nevada corporation ("Med Gen".) The address of the principal executive office of Med Gen is 7284 W. Palmetto Park Road, Suite 207, Boca Raton, Florida 33433; telephone (561) 750-1100. ITEM 2. IDENTITY AND BACKGROUND. (a) This Schedule 13D is filed by Paul Kravitz on behalf of himself. (b) Paul Kravitz has his principal business and office address at 7284 W. Palmetto Park Road, Suite 207, Boca Raton, Florida 33433. (c) Paul Kravitz's principal occupation is CEO of Med Gen, Inc. He is employed by Med Gen, Inc. (d) During the last five years, Paul Kravitz has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors.) (e) During the last five years, Paul Kravitz has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where, as a result of such proceeding, a judgment, decree or final order was entered enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Paul Kravitz is a citizen of the United States. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. See Item 4., Purpose of Transaction, below. CUSIP NO. 58401X-20-9 Page 5 of 5 Pages ITEM 4. PURPOSE OF TRANSACTION. The Board of Directors issued 10,000,000 common shares to Mr. Kravitz as an inducement for his personal guarantee for merchant banking lines of credit. The Company's financials are filed with a "going concern" and the Company is unable to independently secure these lines of credit. ITEM 5. INTEREST IN SECURITIES OF MED GEN. Paul Kravitz is the direct owner of 10,178,685 shares, or 43.83 of Med Gen's issued and outstanding common stock. Paul Kravitz has disposed of -0- shares of common stock of Med Gen within the past 60 days and filed Form 4 as required under the Securities Act. In the event of a default on the convertible debenture notes ,NIR Group has the right to receive the proceeds of the sale of the shares owned by Paul Kravitz. He has pledged these shares as collateral for all of the 8% Convertible debentures. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF MED GEN 175,000 shares of common stock are subject to a six-month lock-up agreement and cannot be sold until after 2-12-2006. An additional 10,035,000 shares of common stock were pledged as collateral security for an 8% Convertible Debenture issued to a group of funds by the Company. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. None After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Med Gen, Inc. By:/s/Paul Kravitz --------------------------- Paul Kravitz, Title: President /s/Paul Kravitz --------------------------- Paul Kravitz, Individually -----END PRIVACY-ENHANCED MESSAGE-----